[Use of rifampicin in treating inflammatory complications in traumatology].
Rifampicin was used in the treatment of 94 patients with severe posttraumatic purulent complications. Positive results were obtained in 95,2% of cases.
D004341:Drug Evaluation; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000150:complications* / Q000188:drug therapy
D012293:Rifampin
Primenenie rifampitsina v lechenii vospalitel'nykh oslozhneniĭ v travmatologii.